NO20091274L - Farmasoytiske faste doseformer inneholdende forbindelser som er mikro-innesluttet i ioniske vann-uloselige polymere - Google Patents

Farmasoytiske faste doseformer inneholdende forbindelser som er mikro-innesluttet i ioniske vann-uloselige polymere

Info

Publication number
NO20091274L
NO20091274L NO20091274A NO20091274A NO20091274L NO 20091274 L NO20091274 L NO 20091274L NO 20091274 A NO20091274 A NO 20091274A NO 20091274 A NO20091274 A NO 20091274A NO 20091274 L NO20091274 L NO 20091274L
Authority
NO
Norway
Prior art keywords
dosage forms
ionic water
solid dosage
entrapped
micro
Prior art date
Application number
NO20091274A
Other languages
English (en)
Norwegian (no)
Inventor
Antonio A Albano
Navnit Hargovindas Shah
Wantanee Phuapradit
Zhongshui Yu
Lin Zhang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20091274L publication Critical patent/NO20091274L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20091274A 2006-10-13 2009-03-27 Farmasoytiske faste doseformer inneholdende forbindelser som er mikro-innesluttet i ioniske vann-uloselige polymere NO20091274L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85185206P 2006-10-13 2006-10-13
US95440107P 2007-08-07 2007-08-07
PCT/EP2007/060542 WO2008043701A1 (fr) 2006-10-13 2007-10-04 Formes posologiques pharmaceutiques solides contenant des composés micro-incorporés dans des polymères ioniques insolubles dans l'eau

Publications (1)

Publication Number Publication Date
NO20091274L true NO20091274L (no) 2009-05-28

Family

ID=38857877

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091274A NO20091274L (no) 2006-10-13 2009-03-27 Farmasoytiske faste doseformer inneholdende forbindelser som er mikro-innesluttet i ioniske vann-uloselige polymere

Country Status (16)

Country Link
US (1) US20080107725A1 (fr)
EP (1) EP2079447A1 (fr)
JP (1) JP2010505901A (fr)
KR (1) KR20090053858A (fr)
AR (1) AR063259A1 (fr)
AU (1) AU2007306402A1 (fr)
BR (1) BRPI0719880A2 (fr)
CA (1) CA2665604A1 (fr)
CL (1) CL2007002921A1 (fr)
IL (1) IL197871A0 (fr)
MX (1) MX2009003516A (fr)
NO (1) NO20091274L (fr)
PE (1) PE20081461A1 (fr)
RU (1) RU2009117711A (fr)
TW (1) TW200824709A (fr)
WO (1) WO2008043701A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025674A1 (fr) 2007-08-15 2009-02-18 sanofi-aventis Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
WO2011107494A1 (fr) 2010-03-03 2011-09-09 Sanofi Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
WO2011157827A1 (fr) 2010-06-18 2011-12-22 Sanofi Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2013037390A1 (fr) 2011-09-12 2013-03-21 Sanofi Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
EP2760862B1 (fr) 2011-09-27 2015-10-21 Sanofi Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
MX2014009889A (es) * 2012-02-16 2014-11-13 Teva Pharma N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinoli ncarboxamida, preparacion y usos de los mismos.
JO3339B1 (ar) * 2012-09-11 2019-03-13 Shanghai Inst Pharmaceutical Ind شكل مستقر غير متبلور من الأغوميلاتين وعملية تحضيره والتركيبات الدوائية التي تحتوي عليه
EP3228307A1 (fr) * 2016-04-05 2017-10-11 Sandoz Ag Solid dispersion contenant des antagonistes opioides
BR112019011098A2 (pt) * 2016-12-15 2019-10-01 Hua Medicine Shanghai Ltd preparado oral de ativador de glicoquinase e método para preparação do mesmo
AU2019278014A1 (en) * 2018-05-31 2021-01-21 Hua Medicine (Shanghai) Ltd. Pharmaceutical combination, composition and combination formulation containing glucokinase activator and K-ATP channel blocker, preparation method thereof and use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5900425A (en) * 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
DE19515972A1 (de) * 1995-05-02 1996-11-07 Bayer Ag Arzneizubereitungen mit kontrollierter Freisetzung und Verfahren zu ihrer Herstellung
JP5170723B2 (ja) * 1997-01-10 2013-03-27 アボット・ラボラトリーズ 活性薬剤の制御放出用錠剤
DE19732903A1 (de) * 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US20030059471A1 (en) * 1997-12-15 2003-03-27 Compton Bruce Jon Oral delivery formulation
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
EP1027886B1 (fr) * 1999-02-10 2008-07-09 Pfizer Products Inc. Dispersions pharmaceutiques solides
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
ATE304011T1 (de) * 2000-05-03 2005-09-15 Hoffmann La Roche Hydantoin-enthaltende glucokinase aktivatoren
EP1286663B1 (fr) * 2000-05-18 2006-01-18 Therics, Inc. Procede et forme d'un dispositif d'administration de medicament, par exemple enrober un noyau toxique a l'interieur d'une zone non toxique en forme posologique orale
CZ2004747A3 (cs) * 2001-12-21 2004-11-10 Novo Nordisk A/S Deriváty amidů jako GK aktivátory
WO2003080585A1 (fr) * 2002-03-26 2003-10-02 Banyu Pharmaceutical Co., Ltd. Derive aminobenzamide
US8501232B2 (en) * 2002-04-23 2013-08-06 Nanotherapeutics, Inc. Process of forming and modifying particles and compositions produced thereby
US7132425B2 (en) * 2002-12-12 2006-11-07 Hoffmann-La Roche Inc. 5-substituted-six-membered heteroaromatic glucokinase activators
CA2540104A1 (fr) * 2003-09-30 2005-04-07 Solubest Ltd. Nanoparticules hydrosolubles et leur procede de production

Also Published As

Publication number Publication date
KR20090053858A (ko) 2009-05-27
AR063259A1 (es) 2009-01-14
MX2009003516A (es) 2009-04-14
CL2007002921A1 (es) 2008-05-30
US20080107725A1 (en) 2008-05-08
PE20081461A1 (es) 2008-10-18
IL197871A0 (en) 2009-12-24
EP2079447A1 (fr) 2009-07-22
AU2007306402A1 (en) 2008-04-17
RU2009117711A (ru) 2010-11-20
JP2010505901A (ja) 2010-02-25
CA2665604A1 (fr) 2008-04-17
BRPI0719880A2 (pt) 2014-06-10
TW200824709A (en) 2008-06-16
WO2008043701A1 (fr) 2008-04-17

Similar Documents

Publication Publication Date Title
NO20091274L (no) Farmasoytiske faste doseformer inneholdende forbindelser som er mikro-innesluttet i ioniske vann-uloselige polymere
CY1126116T1 (el) Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη
NO20092723L (no) Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer
NO20084712L (no) Nye farmasoytiske forbindelser
NO20083836L (no) N-hydroksyakrylamidforbindelser
NO20080745L (no) Nye peptider for anvendelse i behandling av fedme
MA32200B1 (fr) Nouvelles formulations,comprimes comprenant de telles formulations, leur utilisation et leur procede de preparation
EA201100313A1 (ru) Способ доставки фармацевтической композиции пациенту, нуждающемуся в этом
UA111579C2 (uk) ГЕТЕРОЦИКЛІЧНІ ПОХІДНІ 2-АМІНОБЕНЗО[d]ОКСАЗОЛУ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ ТА ЇХ ЗАСТОСУВАННЯ ДЛЯ ЛІКУВАННЯ ЗАХВОРЮВАННЯ, ПОВ'АНОГО З РІ3-КІНАЗОЮ
MY158019A (en) Controlled activation ingestible identifier
NO20085064L (no) 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20091893L (no) Nye 1,4-benzotiepin-1,1-dioksidderivater som er substituert med benzylgrupper, fremgangsmater for fremstilling av medisiner inneholdende forbindelsene og anvendelse derav.
ATE442349T1 (de) Diacylglycerol-acyltransferase-hemmer
NO20084328L (no) Nye forbindelser
CL2007002427A1 (es) Compuestos derivados heterociclicos, inhibidores de metaloproteinasa de matriz; proceso de preparacion; composicion farmaceutica, util para el tratamiento o profilaxis de enfermedades inflamatorias o desordenes autoinmunes.
WO2008087186A3 (fr) Nouveaux peptides pour le traitement de l'obésité
EA200970081A1 (ru) Соединения, обладающие потенциирующим действием в отношении активности этионамида, и их применения
WO2008144061A3 (fr) Nouvelles compositions comprenant un inhibiteur de phosphodiestérase-5 et leur utilisation dans des procédés de traitement
ATE516796T1 (de) Granulat mit einem pharmazeutischen wirkstoff und einem emulgator und herstellungsverfahren dafür
WO2007089934A3 (fr) Procedes destines a traiter l'alcoolisme et des troubles lies a l'alcool utilisant une polytherapie et des polymeres capables de gonfler
NO20074933L (no) Farmasoytisk sammensetning som innbefatter et indolylmaleimidderivat
WO2009030952A3 (fr) Composés hétérocycliques et leurs procédés d'utilisation
PT103884A (pt) Composições de libertação prolongada e métodos para a sua preparação
ATE507214T1 (de) Neuartige serotonin-wiederaufnahmehemmer als arzneimittel mit peripheriesystem-beschränkter aktivität
NO20090817L (no) Nye kromen- og tiokromenkarboksaminderivater, fremgangsmater for fremstilling av disse og terapeutiske applikasjoner av dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application